Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ
AnaptysBio (0HFQ) Share Price & Analysis
0 Followers
0HFQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.97 - $29.76
Previous Close$18.97
Volume300.00
Average Volume (3M)255.00
Market Cap
$491.34M
Enterprise Value$79.25M
Total Cash (Recent Filing)$431.15M
Total Debt (Recent Filing)$19.06M
Price to Earnings (P/E)N/A
Beta-0.24
Next Earnings
Nov 09, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,487,240
10 Day Avg. Volume0
30 Day Avg. Volume255
Standard Deviation0.24
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)486.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.41
Enterprise Value/Gross Profit7.70
Enterprise Value/Ebitda-0.64
Forecast
1Y Price Target
$34.67Price Target Upside82.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
AnaptysBio News
Pre-EarningsAnaptysBio (ANAB) Q1 Earnings Cheat Sheet
0HFQ FAQ
What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest share price was $18.96 and its highest was $29.75 in the past 12 months.
What is AnaptysBio Inc’s market cap?
Currently, no data Available
When is AnaptysBio Inc’s upcoming earnings report date?
AnaptysBio Inc’s upcoming earnings report date is Nov 09, 2023 which is in 161 days.
How were AnaptysBio Inc’s earnings last quarter?
AnaptysBio Inc released its earnings results on May 11, 2023. The company reported -$1.58 earnings per share for the quarter, missing the consensus estimate of -$1.032 by -$0.548.
Is AnaptysBio Inc overvalued?
According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued.
Does AnaptysBio Inc pay dividends?
AnaptysBio Inc does not currently pay dividends.
What is AnaptysBio Inc’s EPS estimate?
AnaptysBio Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnaptysBio Inc have?
Currently, no data Available
What happened to AnaptysBio Inc’s price movement after its last earnings report?
AnaptysBio Inc reported an EPS of -$1.58 in its last earnings report, missing expectations of -$1.032. Following the earnings report the stock price went down -6.733%.
Which hedge fund is a major shareholder of AnaptysBio Inc?
Among the largest hedge funds holding AnaptysBio Inc’s share is Baker Bros Advisors LP. It holds AnaptysBio Inc’s shares valued at 17M.
---
AnaptysBio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.67 (82.79% Upside)
$34.67 (82.79% Upside)
Blogger Sentiment
Bullish
GB:0HFQ Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.59%
12-Months-Change
Fundamentals
Return on Equity
-52.40%
Trailing 12-Months
Asset Growth
-11.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AnaptysBio Inc
AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
---
Design Therapeutics
―
Seres Therapeutics
―
IDEAYA Biosciences
―
Gossamer Bio
―
Agenus
―
---